Close
ACHEMA MIDDLE EAST 2026

Tag: Europe

KIP THE HUMANS: DRUG DISCOVERY BY SIMULATING CELLS

The future of medicine, we're often told, will be personalized. We'll have gene therapies, wearables to monitor our vital signs—maybe even new kinds of...

AstraZeneca’s Bydureon achieves better glycaemic control than insulin glargine in type 2 diabetes

UK-based AstraZeneca has reported results from its longest, randomised, head-to-head DURATION-3 trial of exenatide once-weekly, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used to...

European Commission grants marketing approval for Teva’s DuoResp Spiromax

Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma and chronic obstructive pulmonary...

Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer

Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy product candidate CV-301 for...

Janssen’s type 2 diabetes drug Vokanamet gets European Commission approval in EU

Janssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU) as a treatment for...

Popular